These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 19539480
1. A new small molecule that directly inhibits the DNA binding of NF-kappaB. Kobayashi T, Yoshimori A, Kino K, Komori R, Miyazawa H, Tanuma SI. Bioorg Med Chem; 2009 Jul 15; 17(14):5293-7. PubMed ID: 19539480 [Abstract] [Full Text] [Related]
2. Inhibition of nuclear factor-kappaB DNA binding by organoselenocyanates through covalent modification of the p50 subunit. Chen KM, Spratt TE, Stanley BA, De Cotiis DA, Bewley MC, Flanagan JM, Desai D, Das A, Fiala ES, Amin S, El-Bayoumy K. Cancer Res; 2007 Nov 01; 67(21):10475-83. PubMed ID: 17974991 [Abstract] [Full Text] [Related]
3. Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships. Sharma RK, Chopra S, Sharma SD, Pande V, Ramos MJ, Meguro K, Inoue J, Otsuka M. J Med Chem; 2006 Jun 15; 49(12):3595-601. PubMed ID: 16759101 [Abstract] [Full Text] [Related]
4. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens. Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Mol Pharmacol; 2005 Aug 15; 68(2):286-97. PubMed ID: 15872117 [Abstract] [Full Text] [Related]
5. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA. Trinh DV, Zhu N, Farhang G, Kim BJ, Huxford T. J Mol Biol; 2008 May 23; 379(1):122-35. PubMed ID: 18436238 [Abstract] [Full Text] [Related]
6. Evans Blue is an inhibitor of nuclear factor-kappa B (NF-kappaB)-DNA binding. Sharma RK, Otsuka M, Pande V, Inoue J, João Ramos M. Bioorg Med Chem Lett; 2004 Dec 20; 14(24):6123-7. PubMed ID: 15546742 [Abstract] [Full Text] [Related]
7. Studies on inhibition mechanism of transcription factor NF-kappaB and DNA binding by chelator pyrogallol red on the basis of its interaction with metal ions. Sharma RK, Chelladurai C, Tiwari AD, Rajor HK, Mehta S, Otsuka M. Bioorg Med Chem; 2008 Oct 01; 16(19):9018-22. PubMed ID: 18801661 [Abstract] [Full Text] [Related]
8. Synthesis and structure-activity relationship study of triazine-based inhibitors of the DNA binding of NF-κB. Fujii S, Kobayashi T, Nakatsu A, Miyazawa H, Kagechika H. Chem Pharm Bull (Tokyo); 2014 Oct 01; 62(7):700-8. PubMed ID: 24990506 [Abstract] [Full Text] [Related]
9. Molecular mimicry of the NF-kappaB DNA target site by a selected RNA aptamer. Ghosh G, Huang DB, Huxford T. Curr Opin Struct Biol; 2004 Feb 01; 14(1):21-7. PubMed ID: 15102445 [Abstract] [Full Text] [Related]
10. Crystal structure of a free kappaB DNA: insights into DNA recognition by transcription factor NF-kappaB. Huang DB, Phelps CB, Fusco AJ, Ghosh G. J Mol Biol; 2005 Feb 11; 346(1):147-60. PubMed ID: 15663934 [Abstract] [Full Text] [Related]
11. Mutational analysis of the kinetics and thermodynamics of transcription factor NF-kappaB homodimerisation. Day YS, Bacon SL, Hughes-Thomas Z, Blackburn JM, Sutherland JD. Chembiochem; 2002 Dec 02; 3(12):1192-9. PubMed ID: 12465027 [Abstract] [Full Text] [Related]
12. Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide. Laguillier C, Hbibi AT, Baran-Marszak F, Metelev V, Cao A, Cymbalista F, Bogdanov A, Fagard R. FEBS Lett; 2007 Mar 20; 581(6):1143-50. PubMed ID: 17328896 [Abstract] [Full Text] [Related]
13. Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects. Borgatti M, Chilin A, Piccagli L, Lampronti I, Bianchi N, Mancini I, Marzaro G, dall'Acqua F, Guiotto A, Gambari R. Eur J Med Chem; 2011 Oct 20; 46(10):4870-7. PubMed ID: 21864947 [Abstract] [Full Text] [Related]
14. Molecular modeling of the oxidized form of nuclear factor-kappa B suggests a mechanism for redox regulation of DNA binding and transcriptional activation. Chandrasekaran V, Taylor EW. J Mol Graph Model; 2008 Jan 20; 26(5):861-7. PubMed ID: 17644379 [Abstract] [Full Text] [Related]
15. The first pharmacophore model for potent NF-kappaB inhibitors. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW. Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5665-9. PubMed ID: 19726185 [Abstract] [Full Text] [Related]
17. DNA-binding ability of NF-kappaB is affected differently by ERalpha and ERbeta and its activation results in inhibition of estrogen responsiveness. Guzeloglu-Kayisli O, Halis G, Taskiran S, Kayisli UA, Arici A. Reprod Sci; 2008 May 01; 15(5):493-505. PubMed ID: 18579858 [Abstract] [Full Text] [Related]
18. An optimized extended DNA kappa B site that enhances plasmid DNA nuclear import and gene expression. Gonçalves C, Ardourel MY, Decoville M, Breuzard G, Midoux P, Hartmann B, Pichon C. J Gene Med; 2009 May 01; 11(5):401-11. PubMed ID: 19326361 [Abstract] [Full Text] [Related]
19. Structure basis for the inhibitory mechanism of a novel DNase gamma-specific inhibitor, DR396. Sunaga S, Yoshimori A, Shiokawa D, Tanuma S. Bioorg Med Chem; 2006 Jun 15; 14(12):4217-26. PubMed ID: 16574417 [Abstract] [Full Text] [Related]
20. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. Haddad JJ. Mol Immunol; 2009 Dec 15; 47(2-3):205-14. PubMed ID: 19850345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]